The two seasons of COVID-19 and the rise of Xocova
THOUSAND PALMS, CALIF. (KESQ)- COVID-19 activity is increasing nationally as infections are growing or likely growing in 47 states, according to data from the Centers for Disease Control and Prevention. The surge aligns with federal health research identifying a recurring pattern of two distinct COVID-19 peaks each year.
Unlike influenza, which primarily surges during the winter, CDC research shows COVID-19 routinely experiences peaks in both late summer and winter. While national flu activity remains low, researchers believe COVID-19’s twice-a-year cycle is linked to how quickly the virus mutates, allowing new variants to spread outside traditional respiratory-virus seasons. As of mid-August, CDC estimates show infections are declining in zero states.
To combat potential transmission following exposure, the Food and Drug Administration approved a new oral medication called Xocova, generic name ensitrelvir. The drug is authorized for individuals ages 12 and older who have been exposed to someone with COVID-19. Xocova is the first and only oral prescription pill approved to help prevent symptomatic COVID-19 after an exposure. The five-day treatment must be started within 72 hours of exposure to help prevent the virus from developing.
I will have the ful story tonight at 6 on News Channel 3.
Click here to follow the original article.